The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Soluble CD163
Abstract
CD163 is an endocytic receptor for haptoglobin-hemoglobin complexes and is expressed solely on macrophages and monocytes. As a result of ectodomain shedding, the extracellular portion of CD163 circulates in blood as a soluble protein (sCD163) at 0.7-3.9 mg/l in healthy individuals. The function of sCD163 is unknown, but during inflammation and macrophage activation, sCD163 levels increase acutely due to metalloproteinase-mediated cleavage near the cell membrane. It is now evident that sCD163 is very useful as a biomarker of macrophage activation in various inflammatory diseases, such as macrophage activation syndrome, sepsis, and liver disease. Moreover, sCD163 is a general risk marker of comorbidity and mortality in several chronic inflammatory disease states. Recently, sCD163 has been shown to be strongly associated with later development of type 2 diabetes in both lean and obese subjects, likely due to macrophage infiltration of adipose tissue and the liver. This review summarizes the current knowledge on the regulation of sCD163 in normal and pathological states and also deals with analytical aspects of sCD163 measurements in biological samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Henter, J.-I. (2002) · Blood · doi:10.1182/blood-2002-01-0172 · Cited by 900
Buechler, C., Ritter, M., Orsó, E., Langmann, T., Klucken, J., & Schmitz, G. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.97 · Cited by 704
The macrophage: Past, present and future
Gordon, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200737638 · Cited by 625
Zeyda, M., Farmer, D., Todoric, J., Aszmann, O., Speiser, M., Györi, G., Zlabinger, G. J., & Stulnig, T. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803632 · Cited by 558
McDonald, S. D., Han, Z., Mulla, S., Beyene, J., & on behalf of the Knowledge Synthesis Group (2010) · BMJ · doi:10.1136/bmj.c3428 · Cited by 510
Venneri, M. A., Palma, M. D., Ponzoni, M., Pucci, F., Scielzo, C., Zonari, E., Mazzieri, R., Doglioni, C., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-053504 · Cited by 505
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476
Adipose Tissue, Inflammation and Atherosclerosis
Gustafson, B. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3939 · Cited by 469
The macrophage scavenger receptor CD163
Fabriek, B. O., Dijkstra, C. D., & van den Berg, T. K. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.010 · Cited by 454
CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory response
Moestrup, S., & Møller, H. (2004) · Annals of Medicine · doi:10.1080/07853890410033171 · Cited by 442
Self-citationReiss, K., & Saftig, P. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.11.002 · Cited by 423
The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria
Fabriek, B. O., van Bruggen, R., Deng, D. M., Ligtenberg, A. J. M., Nazmi, K., Schornagel, K., Vloet, R. P. M., Dijkstra, C. D., & van den Berg, T. K. (2009) · Blood · doi:10.1182/blood-2008-07-167064 · Cited by 389
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Van Gorp, H., Delputte, P. L., & Nauwynck, H. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.008 · Cited by 357
Burdo, T. H., Lentz, M. R., Autissier, P., Krishnan, A., Halpern, E., Letendre, S., Rosenberg, E. S., Ellis, R. J., & Williams, K. C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir214 · Cited by 336
Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321
Coronary Intraplaque Hemorrhage Evokes a Novel Atheroprotective Macrophage Phenotype
Boyle, J. J., Harrington, H. A., Piper, E., Elderfield, K., Stark, J., Landis, R. C., & Haskard, D. O. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080431 · Cited by 319
Zeyda, M., & Stulnig, T. M. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.07.003 · Cited by 307
Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9919 · Cited by 299
Self-citationBoven, L. A., van Meurs, M., Boot, R. G., Mehta, A. B., Boon, L., Aerts, J. M. F. G., & Laman, J. D. (2004) · American Journal of Clinical Pathology · doi:10.1309/bg5v-a8jr-dqh1-m7hn · Cited by 290
HUMAN MONOCYTES EXPRESS CD163, WHICH IS UPREGULATED BY IL-10 AND IDENTICAL TO p155
Sulahian, T. H., Högger, P., Wahner, A. E., Wardwell, K., Goulding, N. J., Sorg, C., Droste, A., Stehling, M., Wallace, P. K., Morganelli, P. M., et al. (2000) · Cytokine · doi:10.1006/cyto.2000.0720 · Cited by 281
A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily
Law, S. K. A., Micklem, K. J., Shaw, J. M., Zhang, X., Dong, Y., Willis, A. C., & Mason, D. Y. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230940 · Cited by 275
Van Gorp, H., Van Breedam, W., Delputte, P. L., & Nauwynck, H. J. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/005009-0 · Cited by 264
Högger, P., Dreier, J., Droste, A., Buck, F., & Sorg, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1883 · Cited by 253
Higashi-Kuwata, N., Jinnin, M., Makino, T., Fukushima, S., Inoue, Y., Muchemwa, F. C., Yonemura, Y., Komohara, Y., Takeya, M., Mitsuya, H., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3066 · Cited by 252
Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma
Møller, H. J., Peterslund, N. A., Graversen, J. H., & Moestrup, S. K. (2002) · Blood · doi:10.1182/blood.v99.1.378 · Cited by 223
Self-citationRegulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation
van den Heuvel, M. M., Tensen, C. P., van As, J. H., van den Berg, T. K., Fluitsma, D. M., Dijkstra, C. D., Döpp, E. A., Droste, A., van Gaalen, F. A., Sorg, C., et al. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.858 · Cited by 222
Fabriek, B. O., Van Haastert, E. S., Galea, I., Polfliet, M. M. J., Döpp, E. D., Van Den Heuvel, M. M., Van Den Berg, T. K., De Groot, C. J. A., Van Der Valk, P., & Dijkstra, C. D. (2005) · Glia · doi:10.1002/glia.20208 · Cited by 219
Bover, L. C., Cardó-Vila, M., Kuniyasu, A., Sun, J., Rangel, R., Takeya, M., Aggarwal, B. B., Arap, W., & Pasqualini, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8183 · Cited by 216
Macrophage activation syndrome: advances towards understanding pathogenesis
Grom, A. A., & Mellins, E. D. (2010) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000381996.69261.71 · Cited by 211
Etzerodt, A., Maniecki, M. B., Møller, K., Møller, H. J., & Moestrup, S. K. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410235 · Cited by 211
Self-citationHintz, K. A., Rassias, A. J., Wardwell, K., Moss, M. L., Morganelli, P. M., Pioli, P. A., Givan, A. L., Wallace, P. K., Yeager, M. P., & Guyre, P. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.711 · Cited by 209
Nguyen, T. T., Schwartz, E. J., West, R. B., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157940.80538.ec · Cited by 205
Schaer, D. J., Schleiffenbaum, B., Kurrer, M., Imhof, A., Bächli, E., Fehr, J., Moller, H. J., Moestrup, S. K., & Schaffner, A. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00318.x · Cited by 203
Burdo, T. H., Soulas, C., Orzechowski, K., Button, J., Krishnan, A., Sugimoto, C., Alvarez, X., Kuroda, M. J., & Williams, K. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000842 · Cited by 195
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
Le Douce, V., Herbein, G., Rohr, O., & Schwartz, C. (2010) · Retrovirology · doi:10.1186/1742-4690-7-32 · Cited by 192
ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
Le Gall, S. M., Maretzky, T., Issuree, P. D. A., Niu, X.-D., Reiss, K., Saftig, P., Khokha, R., Lundell, D., & Blobel, C. P. (2010) · Journal of Cell Science · doi:10.1242/jcs.069997 · Cited by 191
A reappraisal of Gaucher disease—diagnosis and disease management algorithms
Mistry, P. K., Cappellini, M. D., Lukina, E., Özsan, H., Mach Pascual, S., Rosenbaum, H., Helena Solano, M., Spigelman, Z., Villarrubia, J., Watman, N. P., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.21888 · Cited by 189
Weaver, L. K., Hintz-Goldstein, K. A., Pioli, P. A., Wardwell, K., Qureshi, N., Vogel, S. N., & Guyre, P. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205756 · Cited by 173
Hemoglobin and Heme Scavenger Receptors
Nielsen, M. J., Møller, H. J., & Moestrup, S. K. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2792 · Cited by 172
Self-citationCXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages
Gleissner, C. A., Shaked, I., Erbel, C., Böckler, D., Katus, H. A., & Ley, K. (2010) · Circulation Research · doi:10.1161/circresaha.109.199505 · Cited by 165
Droste, A., Sorg, C., & Högger, P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0294 · Cited by 164
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Møller, H. J., Grønbæk, H., Schiødt, F. V., Holland-Fischer, P., Schilsky, M., Munoz, S., Hassanein, T., & Lee, W. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.014 · Cited by 163
Self-citationInflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients
Torres, S., De Sanctis, J., de Briceno, L. M., Hernandez, N., & Finol, H. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810419 · Cited by 163
Characterization of an enzyme-linked immunosorbent assay for soluble CD163
Møller, H. J., Hald, K., & Moestrup, S. K. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102760145852 · Cited by 162
Self-citationSoluble CD163: a marker molecule for monocyte/macrophage activity in disease
Møller, H. J., Aerts, H., Grøbæk, H., Peterslund, N. A., Petersen, P. H., Hornung, N., Renjmark, L., Jabbarpour, E., & Moestrup, S. K. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102762377466 · Cited by 162
Self-citationThe macrophage: the intersection between HIV infection and atherosclerosis
Crowe, S. M., Westhorpe, C. L. V., Mukhamedova, N., Jaworowski, A., Sviridov, D., & Bukrinsky, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809580 · Cited by 160
The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor
Fabriek, B. O., Polfliet, M. M. J., Vloet, R. P. M., van der Schors, R. C., Ligtenberg, A. J. M., Weaver, L. K., Geest, C., Matsuno, K., Moestrup, S. K., Dijkstra, C. D., et al. (2007) · Blood · doi:10.1182/blood-2006-08-036467 · Cited by 149
The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis
Aristoteli, L. P., Møller, H. J., Bailey, B., Moestrup, S. K., & Kritharides, L. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.004 · Cited by 147
Self-citationMolecular Characterization of the Haptoglobin·Hemoglobin Receptor CD163
Madsen, M. M., Møller, H. J., Nielsen, M. J., Jacobsen, C. B., Graversen, J. H., van den Berg, T. K., & Moestrup, S. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409629200 · Cited by 143
Self-citationThe CD163-expressing macrophages recognize and internalize TWEAK
Moreno, J. A., Muñoz‐García, B., Martı́n-Ventura, J. L., Madrigal‐Matute, J., Orbe, J., Páramo, J. A., Ortega, L. M., Egido, J., & Blanco‐Colio, L. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.033 · Cited by 141
Levy, A. P., Purushothaman, K., Levy, N. S., Meerarani, P., Strauss, M., Asleh, R., Marsh, S., Cohen, O., Moestrup, S. K., Møller, H. J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149435 · Cited by 137
Self-citationDifferential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals
Tippett, E., Cheng, W., Westhorpe, C. L. V., Cameron, P. U., Brew, B. J., Lewin, S. R., Jaworowski, A., & Crowe, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019968 · Cited by 134
Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*
Møller, H. J., Moestrup, S. K., Weis, N. M., Wejse, C. M., Nielsen, H. I., Pedersen, S. S., Attermann, J., Nexø, E., & Kronborg, G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239120.32490.ab · Cited by 133
Self-citationUp-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors
Weaver, L. K., Pioli, P. A., Wardwell, K., Vogel, S. N., & Guyre, P. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706428 · Cited by 133
Baeten, D., Møller, H. J., Delanghe, J., VEYS, E. M., Moestrup, S. K., & Keyser, F. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20174 · Cited by 131
Self-citationMacrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
Avčin, T., Tse, S. M. L., Schneider, R., Ngan, B., & Silverman, E. D. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.070 · Cited by 125
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
Holland‐Fischer, P., Grønbæk, H., Sandahl, T. D., Moestrup, S. K., Riggio, O., Ridola, L., Aagaard, N. K., Møller, H. J., & Vilstrup, H. (2011) · Gut · doi:10.1136/gut.2010.234542 · Cited by 125
Self-citationSoluble CD163 Inhibits Phorbol Ester-Induced Lymphocyte Proliferation
Högger, P., & Sorg, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5845 · Cited by 117
IL-10 expression profiling in human monocytes
Williams, L. M., Járai, G., Smith, A. J., & Finan, P. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.800 · Cited by 115
Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
Møller, H. J., Frikke‐Schmidt, R., Moestrup, S. K., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.154724 · Cited by 112
Self-citationMatsushita, N., KASHIWAGI, M., Wait, R., Nagayoshi, R., Nakamura, M., Matsuda, T., Högger, P., Guyre, P. M., Nagase, H., & MATSUYAMA, T. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01963.x · Cited by 112
Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels
Davis, B. H., & Zarev, P. V. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20031 · Cited by 109
Møller, H., de Fost, M., Aerts, H., Hollak, C., & Moestrup, S. K. (2004) · European Journal of Haematology · doi:10.1046/j.0902-4441.2003.00193.x · Cited by 108
Self-citationRamanathan, M. K., Weinstock‐Guttman, B., Nguyen, L. T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C. M., & Jacobs, L. R. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00308-3 · Cited by 108
Hiraoka, A., Horiike, N., Akbar, S. M. F., Michitaka, K., Matsuyama, T., & Onji, M. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-004-1493-8 · Cited by 102
Frings, W., Dreier, J., & Sorg, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03142-3 · Cited by 102
Maniecki, M. B., Møller, H. J., Moestrup, S. K., & Møller, B. K. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.019 · Cited by 99
Self-citationFischer, T., Tedaldi, E., & Rappaport, J. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0193 · Cited by 97
Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.
Backé, E., Schwarting, R., Gerdes, J., Ernst, M., & Stein, H. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.11.936 · Cited by 92
Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio
Moreno, J. A., Dejouvencel, T., Labreuche, J., Smadja, D. M., Dussiot, M., Martín-Ventura, J. L., Egido, J., Gaussem, P., Emmerich, J., Michel, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203364 · Cited by 87
Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis
Schaer, D. J., Schaer, C. A., Schoedon, G., Imhof, A., & Kurrer, M. O. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00730.x · Cited by 85
Agardh, H. E., Folkersen, L., Ekstrand, J., Marcus, D., Swedenborg, J., Hedin, U., Gabrielsen, A., & Paulsson‐Berne, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02304.x · Cited by 83
Fonseca, J. E., Edwards, J., Blades, S., & Goulding, N. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10207 · Cited by 83
Carrol, E. D., Mankhambo, L., Jeffers, G., Parker, D., Guiver, M., Newland, P., Banda, D. L., The IPD Study Group, MOLYNEUX, E. M., Heyderman, R. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006621 · Cited by 79
Bersinger, N. A., von Roten, S., Wunder, D. M., Raio, L., Dreher, E. F., & Mueller, M. D. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.010 · Cited by 77
Timmermann, M., & Högger, P. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.031 · Cited by 74
Axelsson, J., Møller, H. J., Witasp, A., Qureshi, A. R., Carrero, J. J., Heimbürger, O., Barany, P. F., Alvestrand, A., Lindholm, B., Moestrup, S. K., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.022 · Cited by 73
Self-citationTNF in Host Resistance to Tuberculosis Infection
Quesniaux, V. F. J., Jacobs, M., Allie, N., Grivennikov, S. I., Nedospasov, S. A., Garcia, I., Olleros, M. L., Shebzukhov, Y. V., Kuprash, D. V., Vasseur, V., et al. (2010) · Current directions in autoimmunity · doi:10.1159/000289204 · Cited by 69
Macrophage activation syndrome: Serological markers and treatment with anti-thymocyte globulin
Coca, A., Bundy, K. W., Marston, B. A., Huggins, J., & Looney, R. J. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.02.005 · Cited by 69
Macrophages: Promising Targets for the Treatment of Atherosclerosis
Wilson, H. M., Barker, R. N., & Erwig, L. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787455635 · Cited by 69
Ritter, M., Buechler, C., Langmann, T., & Schmitz, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0866 · Cited by 68
Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis
Fabriek, B. O., Møller, H. J., Vloet, R. P. M., van Winsen, L. M. L., Hanemaaijer, R., Teunissen, C. E., Uitdehaag, B. M. J., van den Berg, T. K., & Dijkstra, C. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.016 · Cited by 65
Self-citationCross-linking of FcγR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163
Sulahian, T. H., Pioli, P. A., Wardwell, K., & Guyre, P. M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003523 · Cited by 64
Gaïni, S., Pedersen, S. S., Koldkjær, O. G., Pedersen, C. D., Moestrup, S. K., & Møller, H. J. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03586.x · Cited by 63
Self-citationThe macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants
Nielsen, M. J., Madsen, M. M., Møller, H. J., & Moestrup, S. K. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005602 · Cited by 63
Self-citationGlucocorticoid-Induced Appearance of the Macrophage Subtype RM 3/1 in Peripheral Blood of Man
Zwadlo‐Klarwasser, G., Bent, S., Haubeck, H.-D., Sorg, C., & Schmutzler, W. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235111 · Cited by 61
Shakeri-Manesch, S., Zeyda, M., Huber, J. C., Ludvik, B. H., Prager, G., & Stulnig, T. M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.160 · Cited by 61
Møller, H. J., Nielsen, M. J., Maniecki, M. B., Madsen, M. M., & Moestrup, S. K. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.003 · Cited by 61
Self-citationExpression of CD163 in the liver of patients with viral hepatitis
Hiraoka, A., Horiike, N., Akbar, S. M. F., Michitaka, K., Matsuyama, T., & Onji, M. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.10.006 · Cited by 59
The role of TNF in parasitic diseases: Still more questions than answers
Körner, H., McMorran, B. J., Schlüter, D., & Fromm, P. D. (2010) · International Journal for Parasitology · doi:10.1016/j.ijpara.2010.03.011 · Cited by 56
Rahman, S. H., Menon, K. V., Holmfield, J. H. M., McMahon, M. J., & Guillou, J. P. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000245471.33987.4b · Cited by 56
Microarray Analysis Reveals Overexpression of CD163 and HO-1 in Symptomatic Carotid Plaques
Ijäs, P. H., Nuotio, K., Saksi, J., Soinne, L., Saimanen, E. I. T., Karjalainen‐Lindsberg, M., Salonen, O. L. M., Sarna, S. J., Tuimala, J., Kovanen, P. T., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251991.64617.e7 · Cited by 56
Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity
Sporrer, D., Weber, M., Wanninger, J., Weigert, J., Neumeier, M., Stögbauer, F., Lieberer, E., Bala, M., Köpp, A., Schäffler, A., et al. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02170.x · Cited by 53
Development of an ELISA to measure soluble CD163 in biological fluids
Sulahian, T. H., Hintz, K. A., Wardwell, K., & Guyre, P. M. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00328-3 · Cited by 52
Knudsen, T. B., Larsen, K. R., Kristiansen, T. B., Møller, H. J., Tvede, M., Eugen‐Olsen, J., & Kronborg, G. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540601113685 · Cited by 52
Self-citationKnudsen, T. B., Gustafson, P., Kronborg, G., Kristiansen, T. B., Moestrup, S. K., Nielsen, J., Gomes, V., Aaby, P., Lisse, I. M., Møller, H. J., et al. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01229.x · Cited by 50
Self-citationYunoki, K., Naruko, T., Komatsu, R., Ehara, S., Shirai, N., Sugioka, K., Nakagawa, M., Kitabayashi, C., Ikura, Y., Itoh, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp257 · Cited by 44
Levels of Soluble CD163 and Severity of Malaria in Children in Ghana
Kusi, K. A., Gyan, B. A., Goka, B. Q., Dodoo, D., Adjei, G. O., Troye‐Blomberg, M., Akanmori, B. D., & Adjimani, J. P. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00506-07 · Cited by 43
Walter, R. B., Bächli, E., Schaer, D. J., Rüegg, R., & Schoedon, G. (2003) · Blood · doi:10.1182/blood-2002-11-3414 · Cited by 42
Goldstein, J. I., Goldstein, K. A., Wardwell, K., Fahrner, S. L., Goonan, K. E., Cheney, M. D., Yeager, M. P., & Guyre, P. M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00297-1 · Cited by 41
Bächli, E., Schaer, D. J., Walter, R. B., Fehr, J., & Schoedon, G. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605309 · Cited by 39
Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery
Vogel, I., Grove, J., Thorsen, P., Moestrup, S. K., Uldbjerg, N., & Møller, H. J. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00557.x · Cited by 36
Self-citationSerum Soluble CD163 and Interleukin-6 Levels in Women with Ovarian Endometriomas
Jee, B. C., Suh, C. S., Kim, S. H., & Moon, S. Y. (2008) · Gynecologic and Obstetric Investigation · doi:10.1159/000119091 · Cited by 36
Maniecki, M. B., Etzerodt, A., Moestrup, S. K., Møller, H. J., & Graversen, J. H. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.02.001 · Cited by 35
Self-citationGaucher disease: a model disorder for biomarker discovery
Boot, R. G., van Breemen, M. J., Wegdam, W., Sprenger, R. R., de Jong, S. M., Speijer, D., Hollak, C. E. M., van Dussen, L., Hoefsloot, H. C. J., Smilde, A. K., et al. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.54 · Cited by 31
Maniecki, M. B., Hasle, H., Friis-Hansen, L. J., Lausen, B., Nielsen, O. J., Bendix, K., Moestrup, S. K., & Møller, H. J. (2008) · Blood · doi:10.1182/blood-2007-09-114165 · Cited by 29
Self-citationKowal, K., Møller, H. J., DuBuske, L. M., Moestrup, S. K., & Bodzenta‐Łukaszyk, A. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02573.x · Cited by 28
Self-citationGaïni, S., Koldkjær, O. G., Pedersen, S. S., Pedersen, C., Moestrup, S. K., & Møller, H. J. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_341.x · Cited by 27
Self-citationFunding, M., Vorum, H., Nexø, E., et al. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.00397.x · Cited by 26
Chung, S., Kim, J.-E., Park, S., Han, K. S., & Kim, H. K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.12.021 · Cited by 26
Yamazaki, H., Ohta, K., Tsukiji, H., Toma, T., Hashida, Y., Ishizaki, A., Saito, T., Arai, S., Koizumi, S., & Yachie, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.136 · Cited by 25
Vogel, I., Goepfert, A. R., Møller, H. J., Cliver, S., Thorsen, P., & Andrews, W. W. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.009 · Cited by 23
Self-citationSerum levels of soluble CD163 correlate with the inflammatory process in coeliac disease
Daly, A. K., Walsh, C., Feighery, C., O’Shea, U., Jackson, J., & Whelan, A. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03012.x · Cited by 21
Soluble CD163 levels in children with sickle cell disease
Møller, H. J., Nielsen, M. J., Bartram, J. L., Dick, M. C., Height, S. E., Moestrup, S. K., & Rees, D. C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08580.x · Cited by 20
Self-citationSimoni, J. M., Simoni, G., Griswold, J., Moeller, J. F., Tsikouris, J. P., Khanna, A., Roongsritong, C., & Wesson, D. E. (2006) · ASAIO Journal · doi:10.1097/01.mat.0000235282.89757.9f · Cited by 19
Philippidis, P., Athanasiou, T., Nadra, I. J., Ashrafian, H., Haskard, D. O., Landis, R. C., & Taylor, K. M. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.12.043 · Cited by 14
The diagnostic value of soluble CD163 in patients presenting with chest pain
Willemsen, H. M., van der Horst, I. C. C., Nieuwland, W., Slart, R., Zeebregts, C. J., de Boef, E., Schuitemaker, J. H. N., Zijlstra, F., & Tio, R. A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.028 · Cited by 13
Paidas, M. J., Ku, D.-H., Davis, B. H., Lockwood, C. J., & Arkel, Y. S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00681.x · Cited by 11
Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery
Koláčková, M., Lonský, V., Kudlová, M., Manďák, J., Kunes, P., Svitek, V., Jankovičová, K., Vlášková, D., Andrýs, C., & Krejsek, J. (2009) · Perfusion · doi:10.1177/0267659109348723 · Cited by 10
Quimby, K. R., Greenidge, A., Harris, A., & Landis, R. C. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20524 · Cited by 7
Cited by
CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects
Etzerodt, A., & Moestrup, S. K. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4834 · Cited by 604
How I treat hemophagocytic lymphohistiocytosis in the adult patient
Schram, A. M., & Berliner, N. (2015) · Blood · doi:10.1182/blood-2015-01-551622 · Cited by 414
Mechanisms, biomarkers and targets for adult-onset Still’s disease
Feist, E., Mitrovic, S., & Fautrel, B. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0081-x · Cited by 394
Burdo, T. H., Weiffenbach, A., Woods, S. P., Letendre, S., Ellis, R. J., & Williams, K. C. (2013) · AIDS · doi:10.1097/qad.0b013e32836010bd · Cited by 263
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 261
Metadata
- Authors
- Møller, H. J.
- Venue
- Scandinavian Journal of Clinical and Laboratory Investigation
- Publisher
- Informa UK Limited
- Published
- 2011-11-07
- Volume
- 72
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0036-5513 (ISSN-L)
- 1502-7686
- OpenAlex
- W4210975044
- Cited by
- 343
- References
- 127
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.